242: How blockbusters get made, new vaccines for RSV, and mRNA's Q score
Journalist Nathan Vardi joins us to talk about his new book delving into the race to develop the lifesaving cancer drug now called Imbruvica, involving a Scientologist CEO and secretive investor seeking redemption after the worst trade of his life. We also discuss the latest news in the life scienc…
For Blood and Money
On episode 78 of The Compound and Friends, Michael Batnick and Downtown Josh Brown are joined by Nathan Vardi to discuss Nathan's book (For Blood and Money), the biotech landscape, hedge fund returns, the stock market GOAT, venture capital, why the market is rallying, and much more!
To learn more …
Episode 119: BTK-Inhibitor Development: A Researcher's Perspective
Few drugs in oncology have transformed the way we take care of patients. Ibrutinib is one such drug, and it belongs to a class called "BTK inhibitors"In this episode, Chadi captures the story of developing the drug through the eyes of Dr. Jeff Sharman, a prolific investigator and researcher; he is …
Episode 120: For Blood and Money: A Biotech Story
Nathan Vardi, managing editor at MarketWatch, and author of the new book “For Blood and Money: Billionaires, Biotech, and the Quest for a Blockbuster Drug,” is the guest of honor on today’s show. Nathan divulges on what happened behind closed doors for the creation of BTK inhibitors. Everything at …
Episode 53
On this week’s episode of Biotech Hangout, For Blood and Money: Billionaires, Biotech, and the Quest for a Blockbuster Drug author, Nathan Vardi, joins hosts Daphne Zohar, Josh Schimmer, Tim Opler and guest Barbara Ryan. They start the discussion recapping the fallout from the collapse of Silicon V…
36. Pearl of Wisdom: Shaping Genomic Therapies & Community Research with Dr. Jocelynn Pearl
Episode Description:
Jocelynn Pearl, a life scientist, podcast host, and advocate for decentralized science, joins Karl and Erum to discuss the future of biotech and the exciting developments happening in the field. Jocelynn shares her experiences in gene editing, specifically with zinc fingers an…
76. Not Boring Century of Biotech with Elliot Hershberg
Episode Description:
Elliot Hershberg, a computational biologist, writer, and investor, joins Karl and Erum to explore the fascinating intersection of technology, biology, and philosophy. They explore the power of technology-based newsletters, the economics of fermentation, the role of AI in bio…
Ep 2: Evolution of Biotech with Keith Robison
Watch on YouTube here
Chapters00:00 Evolution of Biotech: Past and Present05:29 Understanding Sequencing: Basics and Importance10:07 The Drug Development Process: Then and Now17:18 The Shift from Small Molecules to Biologics22:11 Chance and Unpredictability in Drug Discovery26:35 Sequencing Techno…
Forbes' Hank Tucker on Finding Stories, Asking Better Questions, and Being a Great Teammate
Forbes reporter Hank Tucker hasn't been in the business long, but he has started to make an impact. His profiles on some of the most successful leaders in business coupled with popular articles about interesting investment has made him a compelling read. And he's only getting started. On this episo…
PODCAST SØGEMOTOR
Du kan bruge vores hjemmeside til at søge efter3,831,932podcasts og196,890,466episoder efter personer, steder eller emner.
I have no special talent. I am only passionately curious, and
I listen to podcasts.
‐ Albert "Llamacorn" Einstein
REDIG
Tak fordi du hjælper med at holde podcast-databasen opdateret.
